Exagen Share Price

Exagen Share Price

NASDAQ: XGN | Micro Cap | Healthcare
$3.92
+$0.14 (3.70%) Last updated on 19 Nov, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Exagen Stock Performance

Open
$3.77
Prev. Close
$3.78
Circuit Range
N/A
Day Range
$3.69 - $3.94
Year Range
$2.61 - $9.21
Volume
15,514
Average Traded
$3.83

Exagen Share Price Today

As of 19 November 2026, Exagen Inc.'s share price is $3.92. The stock opened at $3.77, compared to its previous close of $3.78. During today's trading session, Exagen Inc.'s share price traded between $3.69 and $3.94, with an average price of $3.81. Over the past 52 weeks, the stock has recorded a high of $9.21 and a low of $2.61. In terms of performance, Exagen Inc.'s share price has declined by 21.21% over the last six months and is down 50.44% on a year-on-year basis.

Exagen Share Price Chart

Line chart of the Exagen price trend over the selected period. The price rose overall, ranging from 3.58 to 3.94, ending at 3.92.
$3.69$3.94
L
Show Current Price
H

Exagen Stock Fundamentals & Key Indicators

Market Cap
$84.51M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.71
Revenue (TTM)
$66.58B
Return On Equity (TTM)
-131.92%
Profit Margin
-29.96%
Debt to Equity
1.84
Quarterly Earnings Growth YoY
-35.76%

Exagen Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$16.63$17.31$19.94$18.42
Net Profit-$4.67-$3.97-$3.20-$6.34
Net Profit Margin-28.08%-22.93%-16.05%-34.42%
Income ChangeN/A14.99%19.40%-98.12%

Exagen Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$45.56$52.55$55.64$66.58
Net Profit-$47.39-$23.69-$15.12-$19.95
Net Profit Margin-104.02%-45.08%-27.17%-29.96%
Income ChangeN/A50.01%36.18%-31.94%

Exagen Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets9.138.239.113.61
Current Assets48.8936.4647.8472.61
Total Assets58.0244.6956.9486.22
Non Current Liabilities26.4121.6422.3534.14
Current Liabilities14.1613.5111.99.62
Total Liabilities40.5735.1534.2543.76
Shareholders' Equity17.459.5422.6942.46

Exagen Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-13.63-13.28-14.46-32.14
Investing-0.63-0.52-0.8-4.32
Financing24.44-0.66-10.63-0.49

About Exagen

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Exagen Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$8.59
$3.93
-54.12%
Oct 2026
$8.10
$8.56
+5.62%
Sep 2026
$7.21
$8.11
+7.90%
Aug 2026
$4.61
$7.51
+65.35%
Jul 2026
$4.78
$4.54
-2.57%
Jun 2026
$5.10
$4.67
-6.23%
May 2026
$2.99
$4.97
+71.26%
Apr 2026
$3.07
$2.90
-3.17%
Mar 2026
$3.50
$3.00
-16.90%
Feb 2026
$3.62
$3.61
-1.37%
Jan 2026
$6.07
$3.66
-39.90%
Dec 2025
$7.70
$6.09
-23.01%

Exagen Share Price FAQs